Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Morphologic, immunophenotypic, molecular genetic, and clinical characterization in patients with SRSF2-mutated acute myeloid leukemia.

American journal of clinical pathology - 2 Nov 2023

Tatarian Joshua, Tupper Natalie, Li Peng, Feusier Julie, Abdo Maryam, Hyter Stephen, Gonzales Patrick R, Zhang Da, Woodroof Janet, Kelting Sarah, Godwin Andrew K, Cui Wei

Abstract excerpt

OBJECTIVES: SRSF2 mutations are known to be associated with poor outcomes in myelodysplastic neoplasm, but studies on their prognostic impact on acute myeloid leukemia (AML) remain limited. In this retrospective study, we analyzed clinical and pathologic characteristics of patients with AML and correlated the outcomes with SRSF2 mutations. METHODS: We characterized the morphologic, immunophenotypic, molecular,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Leukemia, Myeloid, Acute
Share to Molecular Biology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Prognosis

Share to RNA-Binding Proteins

Share to Serine-Arginine Splicing Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 37458189
DOI: 10.1093/ajcp/aqad077
PMCID: PMC10629464

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Morphologic, immunophenotypic, molecular genetic, and clinical characterization in patients with SRSF2-mutated acute myeloid leukemia.PMID 37458189Read ↗

Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes.Semantic proximity Read ↗

The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution.Semantic proximity Read ↗

Clinical and prognostic profile of SRSF2 and related spliceosome mutations in patients with acute myeloid leukemia.Semantic proximity Read ↗

Identification of a specific immunophenotype associated with a consistent pattern of genetic mutations including SRFS2 and gene expression profile in MDS.Semantic proximity Read ↗

Clinical and prognostic profile of SRSF2 and related spliceosome mutations in patients with acute myeloid leukemiaSemantic proximity Read ↗

Prognostic value of SRSF2 mutations in patients with de novo myelodysplastic syndromes: A meta-analysis.Semantic proximity Read ↗

Genetic analysis of patients with leukemic transformation of myeloproliferative neoplasms shows recurrent SRSF2 mutations that are associated with adverse outcome.Semantic proximity Read ↗

SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition.Semantic proximity Read ↗

Characterisation and prognostic impact Of ZRSR2 mutations in myeloid neoplasmsSemantic proximity Read ↗

Co-occurring mutations in ASXL1, SRSF2, and SETBP1 define a subset of myelodysplastic/ myeloproliferative neoplasm with neutrophilia.Semantic proximity Read ↗

Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2P95-mutated neoplasms.Semantic proximity Read ↗

SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.